Obesity Clinical Trial
— MINDSETSOfficial title:
The Effects of Mindsets on the Brain's Response to Food Cues
Previous studies have shown that obese individuals exhibit greater reward-related brain
activity in response to food cues than lean individuals and our group has shown that
successful weight loss maintainers who were previously obese and now maintain a healthy
weight have increased control-related activity when viewing food cues. These findings
suggest key roles for both reward-related brain areas and inhibitory control regions in
eating behavior. However, no studies to date have examined (a) whether the response to food
cues (i.e., cue-reactivity) can be changed in obese individuals, (b) which strategies are
most effective at altering brain response to food cues, or (c) the neural mechanisms that
support such change.
Given the omnipresent environmental cues to eat and the association between heightened
reward-responsivity and obesity, it is critical to investigate ways to potentially alter
food cue-reactivity in the obese. The most widely employed approach for behavioral weight
loss treatment is Cognitive Behavioral Therapy (CBT), which incorporates strategies to
control and change cognitions (e.g., avoid desire to eat tempting foods by focusing on
something else). This approach is sometimes described as "change- focused" because modifying
negative thoughts is assumed to thereby change associated maladaptive emotions and
behaviors. Alternatively, emerging evidence suggests Acceptance and Commitment Therapy
(ACT), which teaches participants to recognize and accept their cravings as feelings that
need not be acted upon, may also be effective in treating obesity. A third strategy often
employed in smoking cessation and substance abuse treatment is to focus on the long-term
consequences of behaviors, however this form of treatment is not typically used in
behavioral weight loss therapy. Thus although each approach is potentially effective, these
treatment approaches differ greatly in the cognitive strategies they employ.
The primary aim of the proposed research is to compare a cognitive strategy used in CBT
(ʻCHANGEʼ), a cognitive strategy emphasized in ACT (ʻACCEPTʼ), and a cognitive strategy used
in smoking cessation (ʻLATERʼ) relative to a control condition (ʻNOWʼ), in their
effectiveness in altering reward and inhibitory control responses to food cues among obese
individuals.
| Status | Recruiting |
| Enrollment | 35 |
| Est. completion date | March 2014 |
| Est. primary completion date | March 2014 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | Both |
| Age group | 25 Years to 55 Years |
| Eligibility |
Inclusion Criteria: - MRI compatibility - 25-55 yrs old - 25-40 BMI - weight stable - right handed Exclusion Criteria: - MRI incompatibility - left handed |
Observational Model: Case-Only, Time Perspective: Cross-Sectional
| Country | Name | City | State |
|---|---|---|---|
| United States | Weight Control & Diabetes Research Center | Providence | Rhode Island |
| Lead Sponsor | Collaborator |
|---|---|
| The Miriam Hospital | The Obesity Society |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Blood oxygen level dependent (BOLD) signal differences between 4 different mindset conditions in response to food cues | brain response to food cues measured via functional magnetic resonance imaging (fMRI) BOLD signal change will be assessed across all participants while using the 4 different mindsets potential differences in the BOLD response to food cues will be assessed between the 4 mindsets | 1 day (single time point) | No |
| Secondary | behavioral measures of physical activity and eating behavior assessed via questionnaires | behavioral measures of physical activity and eating behavior will be assessed via questionnaires in order to describe the sample | 1 day (single time point) | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
| Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
| Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
| Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
| Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
| Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
| Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
| Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
| Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
| Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
| Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
| Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
| Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
| Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
| Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
| Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
| Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |